Affordable Access

Publisher Website

(R)-ACX is a novel sufonylurea compound with potent, quick and short-lasting hypoglycemic activity

Authors
Journal
European Journal of Pharmacology
0014-2999
Publisher
Elsevier
Publication Date
Volume
389
Identifiers
DOI: 10.1016/s0014-2999(99)00922-x
Keywords
  • (R)-Acx
  • Sulfonylurea Compound
  • Insulin Releasing Effect
  • Hypoglycemic Effect

Abstract

Abstract We investigated the mechanism of the hypoglycemic effect of ( R)-4-(1-acetoxyethyl)- N-(cyclohexylcarbamoyl)benzene-sulfonamide [( R)-acetoxyhexamide; ( R)-ACX], a new sulfonylurea compound. ( R)-ACX potently stimulated the release of insulin from cultured pancreatic β-cells (HIT T15 cells), established from hamster islet cells SV40-transformed. When ( R)-ACX was orally administered to fasted rats, it decreased the plasma glucose level in a dose-dependent manner. The hypoglycemic effect of ( R)-ACX was quick and short lasting, as compared to that of acetohexamide and glibenclamide. The quick and short-lasting hypoglycemic effect of ( R)-ACX was thought likely to result from rapid absorption of ( R)-ACX and rapid elimination of ( R)-ACX and its metabolite, ( R)-hydroxyhexamide. Furthermore, ( R)-ACX was found to suppress the increase of blood glucose level due to starch loading in fasted mice. ( R)-ACX may be useful in the control of postprandial hyperglycemia to patients with non-insulin-dependent diabetic mellitus.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments

More articles like this

(R)-ACX is a novel sufonylurea compound with poten...

on European Journal of Pharmacolo... Feb 18, 2000

Nursing shortage requires lasting solution, not a...

on Health progress (Saint Louis,... May 1987

A novel homoisocarbacyclin analog with potent and...

on CHEMICAL & PHARMACEUTICAL BULL... January 1992
More articles like this..